Answers are grounded in this paper and cite their sources.
A new generation of DNA-sequencing platforms will become commercially available over the next few years. These instruments will enable re-sequencing of human genomes at a previously unimagined throughput and low cost. Here, I examine why the 1,000 dollar human genome is an important goal for research and clinical diagnostics, and what will be required to achieve it.
No takes yet. Share an insight, caveat, or question.
Elaine R. Mardis (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: